Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Devriendt

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Journal of Translational Internal Medicine|November 15, 2018
Cardiogenic Shock after Nifedipine Administration in a Pregnant Patient: A Case Report and Review of the LiteratureIlaria Botta, Jacques Devriendt, Jose Castro Rodriguez, et al.
Annals of Intensive Care|July 31, 2021
Outcomes of ICU patients with and without perceptions of excessive care: a comparison between cancer and non-cancer patientsDominique D Benoit, Esther N van der Zee, Michael Darmon, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Journal of Translational Internal Medicine|November 15, 2018
Cardiogenic Shock after Nifedipine Administration in a Pregnant Patient: A Case Report and Review of the LiteratureIlaria Botta, Jacques Devriendt, Jose Castro Rodriguez, et al.
Annals of Intensive Care|July 31, 2021
Outcomes of ICU patients with and without perceptions of excessive care: a comparison between cancer and non-cancer patientsDominique D Benoit, Esther N van der Zee, Michael Darmon, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
Pageof 4